Eyecare biotech jumps 19% after stablecoin-focused pivot
NovaBay Pharmaceuticals was founded in 2000 as a biopharmaceutical company developing eye care products and is now betting big on the Sky protocol and stablecoins.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
NovaBay Pharmaceuticals was founded in 2000 as a biopharmaceutical company developing eye care products and is now betting big on the Sky protocol and stablecoins.
Why this matters
This maps to the Stablecoins hub, so it can help confirm whether that theme is gaining breadth across the crypto news cycle.
Original source
Read on CointelegraphRelated market context
Circle Asks SEC to Clarify Cash Treatment for Qualifying Payment Stablecoins
TL;DR: Circle’s comment letter asks the SEC to align its crypto-asset proposal with payment-stablecoin rules. The company’s reques...
Shopify’s Base USDC Checkout Puts Stablecoins Into Mainstream E-Commerce
TL;DR: The case study referenced more than $42 million of net settled payments and over 448,000 payments on the underlying Commerc...
Ethereum hosts 54% of all stablecoins as tokenized stocks jump 170%
Ethereum's dominance in stablecoins and growth in tokenized stocks could reshape financial markets, influencing blockchain adoptio...
Tokenized stocks could follow stablecoins’ growth path over next five years, Flowdesk CEO says
Tokenized stocks' growth could revolutionize financial markets, enhancing liquidity and accessibility, contingent on regulatory an...
A Nasdaq-listed company may sell $450 million bitcoin, citing Binance hack and quantum fears
Next Technology Holding cited exchange security and quantum computing risks in authorizing sales or loans against its 5,833 BTC. I...
Tether Q3 Profit Hits $1.5B While USDT Reserve Buffer Nearly Doubles to $8B
Key Takeaways: In Q3, Tether achieved an operating profit of $1.5 billion. Reserve assets rose to almost $8 billion. U.S. Treasury...